Restriction Spectrum Imaging (RSI) improves cancer detection

November 18, 2023
< 1 mins

Category: Published research
Product: OnQ Prostate
Disease: Prostate cancer

Compares the diagnostic performance of restriction spectrum imaging (RSI), with that of conventional multi-parametric (MP) magnetic resonance imaging (MRI) for prostate cancer (PCa) detection in a blinded reader-based format. 2016.

Read Here >>

Topic: Published research

More Resources

01/22/2026

Reflecting on a Transformative Year at Cortechs.ai

As we enter 2026, we want to take a moment to reflect on what has been a truly impactful year at Cortechs.ai.

Blogs

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

Blogs

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

Blogs

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

Blogs

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

Cortechs.ai news, Industry news

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

Our solutions

Our solutions

About

Support

Resources